Saundra L. Pelletier

Filings by Saundra L. Pelletier span 2 companies, the busiest being Evofem Biosciences, Inc. and Tracon Pharmaceuticals, Inc. The record holds 31 filings, for trades running from 2 July 2018 to 31 December 2022.

In open-market terms, that means 8 purchases worth €270k on one side and 5 sales worth €580k on the other. Netting one side against the other leaves €310k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 16 share grants.

Half of the purchases are above €32k and half below. 5 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of -9.7%, with the price up in 33% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 26 April 2023, the filings show a transaction in Evofem Biosciences, Inc. The latest purchase dates back some time: it was published 1,607 days ago, on 31 May 2022. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.